Search research articles
Contact Us
Filters
Showing results (131-140 of 315) with videos related to
Page
of 32
Sort By:
Annals of Neurology
|
November 1, 1993
Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism
B J Snow, T G Nygaard, H Takahashi, et al.
Neurology
|
June 1, 1984
Effortful and automatic memory: effects of dopamine
R P Newman, H Weingartner, S A Smallberg, et al.
Neurology
|
December 1, 1977
Experiences with a new ergoline (CF 25-397) in parkinsonism
P F Teychenne, R Pfeiffer, S M Bern, et al.
Postgraduate Medical Journal
|
November 1, 1972
Augmenting the action of levodopa
S K Rao, S D Vakil, D B Calne, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 1, 1987
Local treatment of spasmodic torticollis with botulinum toxin
J K Tsui, R D Fross, S Calne, et al.
Neurology
|
January 15, 2000
Botulinum toxin A as treatment for drooling saliva in PD
P K Pal, D B Calne, S Calne, et al.
Advances in Neurology
|
January 1, 1988
Efficacy of dopamine agonists in dystonia
H Teräväinen, S Calne, K Burton, et al.
Advances in Neurology
|
January 1, 1993
Clinical heterogeneity of dopa-responsive dystonia: PET observations
H Takahashi, B J Snow, T G Nygaard, et al.
Annals of Neurology
|
January 1, 1997
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
F J Vingerhoets, M Schulzer, D B Calne, et al.
Annals of the New York Academy of Sciences
|
May 11, 1992
Theories of neurodegeneration
D B Calne, F H Hochberg, B J Snow, et al.
Page
of 32
Search research articles
Search
Showing results (131-140 of 315) with videos related to
Sort By:
Page
of 32
Annals of Neurology
|
November 1, 1993
Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism
B J Snow, T G Nygaard, H Takahashi, et al.
Neurology
|
June 1, 1984
Effortful and automatic memory: effects of dopamine
R P Newman, H Weingartner, S A Smallberg, et al.
Neurology
|
December 1, 1977
Experiences with a new ergoline (CF 25-397) in parkinsonism
P F Teychenne, R Pfeiffer, S M Bern, et al.
Postgraduate Medical Journal
|
November 1, 1972
Augmenting the action of levodopa
S K Rao, S D Vakil, D B Calne, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
August 1, 1987
Local treatment of spasmodic torticollis with botulinum toxin
J K Tsui, R D Fross, S Calne, et al.
Neurology
|
January 15, 2000
Botulinum toxin A as treatment for drooling saliva in PD
P K Pal, D B Calne, S Calne, et al.
Advances in Neurology
|
January 1, 1988
Efficacy of dopamine agonists in dystonia
H Teräväinen, S Calne, K Burton, et al.
Advances in Neurology
|
January 1, 1993
Clinical heterogeneity of dopa-responsive dystonia: PET observations
H Takahashi, B J Snow, T G Nygaard, et al.
Annals of Neurology
|
January 1, 1997
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
F J Vingerhoets, M Schulzer, D B Calne, et al.
Annals of the New York Academy of Sciences
|
May 11, 1992
Theories of neurodegeneration
D B Calne, F H Hochberg, B J Snow, et al.
Page
of 32